SCHEMBL29617693

SCHEMBL29617693

COc1ccccc1C(=O)NCc1ccc(B2OC(C)(C)C(C)(C)O2)cc1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 9/20 0.55
TP53 P04637 1/20 0.49
GLA P06280 1/20 0.49
ALDH1A1 P00352 4/20 0.47
GAA P10253 1/20 0.47
PKM P14618 1/20 0.47
HTT P42858 1/20 0.47
NPC1 O15118 1/20 0.46
KDM4E B2RXH2 2/20 0.46
RCE1 Q9Y256 1/20 0.46
POLB P06746 1/20 0.46
NLRP3 Q96P20 1/20 0.44
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
PLA2G1B P04054 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43
LMNA P02545 1/20 0.43
CTSD P07339 1/20 0.42
EGFR P00533 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18641948 1.00 HPGD (0.55) HPGDTP53GLAALDH1A1GAA
SCHEMBL18641941 0.92 HPGD (0.60) HPGDTP53GLAALDH1A1GAA
SCHEMBL29617726 0.92 HPGD (0.60) HPGDTP53GLAALDH1A1GAA
SCHEMBL20583708 0.87 HPGD (0.54) HPGDTP53GLAALDH1A1GAA
SCHEMBL24598448 0.86 ROCK1 (0.40) HPGDALDH1A1GAAPKMHTT
SCHEMBL24598597 0.84 MAPK8 (0.46) HPGDGAALMNAKMT2A
SCHEMBL21817011 0.84 HPGD (0.64) HPGDTP53GLAALDH1A1HTT
SCHEMBL29710536 0.83 HPGD (0.52) HPGDTP53GLAALDH1A1GAA
SCHEMBL18641768 0.80 HPGD (0.50) HPGDTP53GLAALDH1A1GAA
SCHEMBL16650820 0.80 HPGD (0.58) HPGDTP53GLAALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114685516-A Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer 洛克索肿瘤学股份有限公司 2022-07-01 CN disclosed
CN-108431007-B Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer 洛克索肿瘤学股份有限公司 2022-06-07 CN disclosed